<?xml version="1.0" encoding="UTF-8"?>
<document id="26252478">
	<sentence id="s1" text="In this study, we investigated the expression of the cancer/testis antigens ADAM2, CALR3 and SAGE1 in lung and breast cancer, the two most frequent human cancers, with the purpose of providing novel therapeutic targets for these diseases.">
		<entity id="s1.e1" charOffset="53-59"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s1.e2" charOffset="76-81"
			type="GENE" text="ADAM2" ontology_id="2515"/>
		<entity id="s1.e3" charOffset="83-88"
			type="GENE" text="CALR3" ontology_id="125972"/>
		<entity id="s1.e4" charOffset="93-98"
			type="GENE" text="SAGE1" ontology_id="55511"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e3" pgr="false"/>
		<pair id="s1.p3" e1="s1.e1"
		    e2="s1.e4" pgr="false"/>
	</sentence>
	<sentence id="s2" text="We used a set of previously uncharacterized antibodies against the cancer/testis antigens ADAM2, CALR3 and SAGE1 to investigate their expression in a large panel of normal tissues as well as breast and lung cancers.">
		<entity id="s2.e1" charOffset="10-13"
			type="GENE" text="set" ontology_id="6418"/>
		<entity id="s2.e2" charOffset="67-73"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s2.e3" charOffset="90-95"
			type="GENE" text="ADAM2" ontology_id="2515"/>
		<entity id="s2.e4" charOffset="97-102"
			type="GENE" text="CALR3" ontology_id="125972"/>
		<entity id="s2.e5" charOffset="107-112"
			type="GENE" text="SAGE1" ontology_id="55511"/>
		<pair id="s2.p1" e1="s2.e3"
		    e2="s2.e3" pgr="false"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e4" pgr="false"/>
		<pair id="s2.p3" e1="s2.e2"
		    e2="s2.e5" pgr="false"/>
		<pair id="s2.p4" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Surprisingly, we detected no ADAM2, CALR3 and SAGE1 in the 67 lung cancers (mainly non-small lung cancer) and 189 breast cancers, while MAGE-A proteins were present in 15% and 7-16% of these tumor types, respectively.">
		<entity id="s3.e1" charOffset="29-34"
			type="GENE" text="ADAM2" ontology_id="2515"/>
		<entity id="s3.e2" charOffset="36-41"
			type="GENE" text="CALR3" ontology_id="125972"/>
		<entity id="s3.e3" charOffset="46-51"
			type="GENE" text="SAGE1" ontology_id="55511"/>
		<entity id="s3.e4" charOffset="67-73"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s3.e5" charOffset="191-196"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e4" pgr="false"/>
		<pair id="s3.p2" e1="s3.e2"
		    e2="s3.e4" pgr="false"/>
		<pair id="s3.p3" e1="s3.e3"
		    e2="s3.e4" pgr="false"/>
		<pair id="s3.p4" e1="s3.e1"
		    e2="s3.e5" pgr="false"/>
		<pair id="s3.p5" e1="s3.e2"
		    e2="s3.e8" pgr="false"/>
		<pair id="s3.p6" e1="s3.e5"
		    e2="s3.e8" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Treatment with DNA methyltransferase inhibitors has been proposed as an attractive strategy to increase the expression of cancer/testis antigens in tumors before immunotargeting; however, neither ADAM2, CALR3 nor SAGE1 could be significantly induced in lung and breast cancer cell lines using this strategy.">
		<entity id="s4.e1" charOffset="122-128"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s4.e2" charOffset="148-153"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s4.e3" charOffset="196-201"
			type="GENE" text="ADAM2" ontology_id="2515"/>
		<entity id="s4.e4" charOffset="203-208"
			type="GENE" text="CALR3" ontology_id="125972"/>
		<entity id="s4.e5" charOffset="213-218"
			type="GENE" text="SAGE1" ontology_id="55511"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e3" pgr="false"/>
		<pair id="s4.p2" e1="s4.e1"
		    e2="s4.e4" pgr="false"/>
		<pair id="s4.p3" e1="s4.e1"
		    e2="s4.e5" pgr="false"/>
		<pair id="s4.p4" e1="s4.e2"
		    e2="s4.e3" pgr="false"/>
		<pair id="s4.p5" e1="s4.e7"
		    e2="s4.e5" pgr="false"/>
		<pair id="s4.p6" e1="s4.e7"
		    e2="s4.e6" pgr="false"/>
	</sentence>
	<sentence id="s5" text="Our results suggest that ADAM2, CALR3 and SAGE1 cancer/testis antigens are not promising targets for immunotherapy of breast and lung cancer.">
		<entity id="s5.e1" charOffset="25-30"
			type="GENE" text="ADAM2" ontology_id="2515"/>
		<entity id="s5.e2" charOffset="32-37"
			type="GENE" text="CALR3" ontology_id="125972"/>
		<entity id="s5.e3" charOffset="42-47"
			type="GENE" text="SAGE1" ontology_id="55511"/>
		<entity id="s5.e4" charOffset="48-54"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s5.p1" e1="s5.e1"
		    e2="s5.e4" pgr="false"/>
		<pair id="s5.p2" e1="s5.e2"
		    e2="s5.e4" pgr="false"/>
		<pair id="s5.p3" e1="s5.e3"
		    e2="s5.e4" pgr="false"/>
	</sentence>
</document>
